Search

Journals

Title Alimentary Pharmacology and Therapeutics

Title Cancer Chemotherapy & Pharmacology

Publications

Clinical pharmacology and PK/PD translation of the second-generation Bruton's tyrosine kinase inhibitor, zanubrutinib. [13-Feb-2022]

Tam C.S.; Ou Y.C.; Trotman J.; Opat S.

Abstract , for the adverse effects seen with other BTK inhibitors. Areas covered: This drug profile covers zanubrutinib clinical pharmacology and the translation of pharmacokinetics (PK) and pharmacodynamics (PD) to clinical efficacy and safety profiles, by highlighting key

Chemoresistance is mediated by ovarian cancer leader cells in vitro. [10-Sep-2021]

Karimnia N.; Wilson A.L.; Green E.; Matthews A.; Jobling T.W. ; Plebanski M.; Bilandzic M.; Stephens A.N.

Neuroimaging Pharmacopoeia [2015]

Chandra, Ronil

Fibromyalgia: Current diagnosis and management. [11-Oct-2012]

Guymer E. ; Littlejohn G.

Recent advancements in targeting the immune system to treat hypertension. [25-Sep-2024]

R Muralitharan R.; Marques F.Z.; O'Donnell J.A.

Drug effects on the mechanical properties of large arteries in humans. [16-Oct-2012]

Hope S.A.; Hughes A.D.

Editorial: UK quality of care drive improving ulcerative colitis hospital outcomes. [29-Aug-2019]

Moore G.

An approach to managing fibromyalgia. [18-Oct-2012]

Guymer E.K. ; Littlejohn G.O.

Macrophages and diabetic nephropathy. [12-Oct-2012]

Tesch G.H.

Orphan neurones and amine excess: The functional neuropathology of Parkinsonism and neuropsychiatric disease. [20-Oct-2012]

Willis G.L.; Armstrong S.M.

Abstract -invasive, pharmacological and surgical modification of functional orphan neurones as they affect adjacent systems. The Orphan neurone/DA excess hypothesis permits a more comprehensive and defendable interpretation of the interrelationship between Parkinsonism

All publications